ISPOR - PGI14 Budget IMPACT Analysis of Tofacitinib in the Treatment of Ulcerative Colitis in the Perspective of Brazilian Public Healthcare System

PGI14 Budget IMPACT Analysis of Tofacitinib in the Treatment of Ulcerative Colitis in the Perspective of Brazilian Public Healthcare System

Abstract

Authors

P. Holanda C. Salgado De Santana T. Senna L. Carmo R.F. Alexandre

Full Text Cite This Article

Back to Volume 24, Supplemental S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now